Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back
Evaluation ViewAttendees 16

Biopharmaceuticals (includes Biologics and Drugs)

Regulatory Opportunities and Challenges with mRNA Technology – Lessons Learned from the COVID-19 Pandemic

Wednesday, October 4, 2023
4:45 PM – 5:45 PM EDT
Location/Room: 511D
Advanced Level
Description: Messenger RNA (mRNA) was discovered in the early 1960’s and research into how mRNA could be delivered into cells was developed in the 1970’s. The global COVID-19 pandemic of 2020 was the first time an mRNA vaccine was brought to market. This session will highlight the science behind mRNA technology and how the regulatory landscape has and continues to evolve pre- and post-pandemic.

Learning Objectives:

  • Explain the science behind mRNA technology and its potential applications
  • Explain regulatory challenges and opportunities that been enabled with mRNA technology.
  • Explain regulatory challenges and opportunities enabled with mRNA technology and regulatory framework